Latest filing published 05 Oct 2026 for Palisade Bio, INC., €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -27.0%Entry US$1.85 · Close 22 Oct 2026 US$1.35
- -30.8%Entry US$1.95 · Close 22 Oct 2026 US$1.35
- -83.9%Entry US$4.61 · Close at T+365 US$0.74
- -83.8%Entry US$8.10 · Close at T+365 US$1.31
- -58.5%Entry US$8.55 · Close at T+365 US$3.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Donald Allen Williams: trading record in brief
This profile gathers the share dealings of Donald Allen Williams across 3 companies, led by Palisade Bio, Inc., Alphatec Holdings, Inc. and Forte Biosciences, Inc. We count 18 filings; the first trade dates from 1 May 2015 and the latest from 2 October 2026.
Every open-market trade on record is a purchase: 9 purchases worth €76k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 7 share grants and 2 option exercises. So far in 2026, the count stands at 4 purchases and no sales.
In size, the median ticket on the buying side is €8,063. Clusters matter here: 4 out of 8 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 7 purchases show a median change of +3.5%, with the price up in 57% of them. Past outcomes like these are no guarantee of what comes next.
On 5 October 2026 came the latest disclosure, an open-market purchase for €13k in Palisade Bio, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Donald Allen Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.420.0056% mcap20.5% of flowCommon StockSEC:0001493152-26-045772:0Canonical exit: 30 Dec 2026 (T+90)
- 10,000 shares@ US$1.460.0058% mcap21.3% of flowCommon StockSEC:0001493152-26-045772:1Canonical exit: 31 Dec 2026 (T+90)
- 5,000 shares@ US$1.671220.2% of flowCommon StockSEC:0001493152-26-003078:0Canonical exit: 16 Apr 2026 (T+90)
- 5,000 shares@ US$1.8822.6% of flowCommon StockSEC:0001493152-26-002107:0Canonical exit: 9 Apr 2026 (T+90)
- 388 shares0Comon Stock, par value $0.01SEC:0001493152-24-047363:0
- 340 shares0Comon Stock, par value $0.01SEC:0001493152-24-023612:0
- 1,000 shares@ US$4.86312.6% of flowComon Stock, par value $0.01SEC:0001493152-24-021777:0Canonical exit: 26 Aug 2024 (T+90)
- 10,000 shares@ US$0.60515.7% of flowCommon Stock, par value $0.01SEC:0001493152-24-004565:0Canonical exit: 30 Apr 2024 (T+90)
- 20,000 shares@ US$0.5428.9% of flowCommon Stock, par value $0.01SEC:0001493152-23-034756:0Canonical exit: 26 Dec 2023 (T+90)
- 59,405 shares@ US$1.01100.0% of flowCommon StockSEC:0001209191-23-044285:0
- 10,221 shares0Common StockSEC:0001179110-21-006874:0
- 26,956 shares0Common StockSEC:0001179110-20-007661:0
- 18,086 shares0Common StockSEC:0001179110-19-008111:0
- 4,000 shares@ US$2.47100.0% of flowCommon StockSEC:0001179110-19-003808:0Canonical exit: 10 Jun 2019 (T+90)
- 20,492 shares0Common StockSEC:0001179110-18-010085:0
- 18,939 shares0Common StockSEC:0001179110-17-009624:0
- 5,000 shares@ US$1.32Common StockSEC:0001181431-15-007183:0Canonical exit: 3 Aug 2015 (T+90)
- 31,034 shares0Restricted Common StockSEC:0001181431-15-007179:0
18 of 18 declarations
